“Not one part of me thinks we won’t be fully e

“Not one part of me thinks we won’t be fully enrolled for the 75% by EOY.”

Historical enrollment for the S/C trial disagrees with your prediction, but that will change if CYDY can increase enrollment across the 15 sites in the U.S. and the pending sites in the U.K. NP has promised an increase in enrollment a few times, including a statement during the last CC that amarex would be visiting sites to help increase the rate. Amarex is small and is already taxed with a U.S. and U.K. HIV BLA, which means that NP needs to throw some additional funds to ensure the plan is executed.

Remember, CYDY is competing for patients against approved drugs, other experimental drugs, a lower hospitalization and death rate (yes, it’s been a increasing recently but still not at levels from late spring), and internal constraints such as limited trial sites and limited financial resources. The struggle is real. We’ll basically be waiting through the first week of November for an official trial enrollment update and we can make a better prediction if 75% enrollment at that time.